Black Diamond Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$82,442,000 over the previous period. Total operating expenses were $86,460,000.
Profit Margin
| 2017 | 0 | -4.60M | |
|---|---|---|---|
| 2018 | 0 | -8.93M | |
| 2019 | 0 | -41.14M | |
| 2020 | 0 | -65.47M | |
| 2021 | 0 | -123.20M | |
| 2022 | 0 | -84.52M | |
| 2023 | 0 | -82.44M |
BDTX Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 437K | 3.23M | 2.21M | 600K | 47K | 0 | 24K |
Gross profit | -437K | -3.23M | -2.21M | -600K | -47K | 0 | -24K |
Operating exp. | |||||||
Research and development | 59.35M | 64.43M | 96.82M | 48.20M | 21.75M | 6.95M | 3.45M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 86.46M | 92.82M | 126.87M | 69.57M | 29.33M | 8.90M | 4.11M |
Operating income | -86.46M | -92.82M | -126.87M | -69.57M | -8.90M | -8.90M | -4.11M |
Other income (expenses), net | 4.01M | 3.90M | 1.27M | 2.31M | -26.35M | -31K | -483K |
Income before tax | -82.44M | -88.91M | -125.59M | -67.25M | -35.25M | -8.93M | -4.60M |
Income tax expense | 0 | -4.39M | -2.39M | -1.77M | 5.88M | -27K | 59K |
Net income | -82.44M | -84.52M | -123.20M | -65.47M | -41.14M | -8.93M | -4.60M |
Earnings per share | |||||||
Basic EPS | -1.88 | -2.33 | -3.4 | -1.99 | -1.15 | -0.64 | -0.64 |
Diluted EPS | -1.88 | -2.33 | -3.4 | -1.99 | -1.15 | -0.64 | -0.64 |
| Data source | Data source | Data source | Data source | Data source |